[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

2017-2022 Global and Japan Estrogen and Progesterone Market Analysis Report

August 2017 | 114 pages | ID: 215B382543CEN
JP Research

US$ 3,085.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Estrogen and Progesterone market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Estrogen and Progesterone market's development status and future trend in the global and Japan. It splits Estrogen and Progesterone market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
  • Gedeon Richter Plc.
  • Bayer Oy
  • N.V.Organon
  • Pfizer Healthcare Ireland
  • Jenapharm GmbH & Co. KG
  • Besins Healthcare Benelux
  • MERCK SERONO LIMITED
  • Abbott Healthcare Products B.V.
  • Teva Pharma - Produtos Farmaceuticos,Lda.
  • Aspen Pharmacare Australia Pty Ltd.
  • Dr.Kade Pharmazeutische Fabrik GmbH
  • F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
  • Eli Lilly Nederland B.V
  • Orion Corporation
  • AstraZeneca UK Limited
  • Novartis Pharma Schweiz AG
Geographically, this report splits the Global market into the following regions:
  • Asia Pacific
    • Japan
      • Tokyo
      • Yokohama
      • Osaka
      • Nagoya
      • Others
    • China
    • Korea
    • India
    • Others
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Russia
    • Others
  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Southeast Asia
    • Singapore
    • Malaysia
    • Vietnam
    • Myanmar
    • Thailand
    • Indonesia
    • Philippines
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • Iran
    • UAE
    • Turkey
    • Israel
    • Egypt
    • South Africa
    • Others
On the basis of product, the Estrogen and Progesterone market is primarily split into

by Progesterone stimulant
  • Norethisterone Acetate
  • Ethynodiol diacetate
  • Levonorgestrel
  • Methylnorethindrone
  • Norelgestromin
  • Desogestrel
  • Etonogestrel
  • Gestodene
  • Norgestimate
  • Drospirenone
  • Nomegestrol
  • Promegestone
  • Trimegestone
  • Dienogest
  • chlormadinone
  • cyproterine
  • Medroxyprogesterone acetate
  • megestrol
  • Gestonorone
  • anhydrohydroxy progesterone
  • Medrogestone
  • Norgestrienone
  • Lynestrenol
  • Norethynodrel
  • Tibolone
  • Dydrogesterone
  • Quingestanol
by Antiprogestogen
  • Aglepristone
  • Mifepristone
  • Asoprisnil
  • Telapristone
  • Ulipristal acetate
by Estrogenic stimulant
  • Megestrol
  • Estradiol
  • Estradiol Acetate
  • Estradiol Benzoate
  • estradiol cypionate
  • Estradiol Dipropionate
  • Estradiol enanthate
  • Estradiol Undecylate
  • Estradiol valerate
  • Polyestradiol phosphate
  • Estriol Triacetate
  • Piperazine Estrone
  • Ethinyl estradiol
  • Mestranol
  • Promestriene
  • Equilenin
  • Equilin
  • Chlorotrianisene
  • Dienoestrol
  • Fosfestrol
  • Diethylstilbestrol
  • Zeranol
by Antiestrogen agent
  • Afimoxifene
  • Arzoxifene
  • Bazedoxifene
  • Clomifene
  • Cyclofenil
  • Epimestrol
  • Lasofoxifene
  • Mepitiostane
  • Nafoxidine
  • Ormeloxifene
  • Raloxifene
  • Tamoxifen
  • Toremifene
  • Fulvestrant
by Aromatase Inhibitor
  • Aminoglutethimide
  • Testolactone
  • Anastrozole
  • Atamestane
  • Exemestane
  • Fadrozole
  • Formestane
  • Letrozole
  • Minamestane
  • Plomestane
  • Vorozole
Main Applications
  • Pharmacy
  • Hospital
  • Department of endocrinology



1 ESTROGEN AND PROGESTERONE OVERVIEW

1.1 Product Overview and Scope of Estrogen and Progesterone
1.2 Global and Japan Estrogen and Progesterone Market by Applications/End Users
  1.2.1 Japan Estrogen and Progesterone Sales () and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan Estrogen and Progesterone Sales () and Market Share by Applications (2012-2017)
    1.2.1.2 Japan Estrogen and Progesterone Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan Estrogen and Progesterone Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global Estrogen and Progesterone Sales by Application (2012-2017)
    1.2.3.1 Global Estrogen and Progesterone Sales () and Market Share by Applications (2012-2017)
    1.2.3.2 Global Estrogen and Progesterone Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global Estrogen and Progesterone Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.5
  1.2.6
1.3 Global and Japan Market Size (Sales and Revenue) of Estrogen and Progesterone (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of Estrogen and Progesterone (2012-2017)
    1.3.1.1 Japan Estrogen and Progesterone Sales () and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan Estrogen and Progesterone Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of Estrogen and Progesterone (2012-2017)
    1.3.2.1 Global Estrogen and Progesterone Sales () and Growth Rate (%) (2012-2017)
    1.3.2.2 Global Estrogen and Progesterone Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Estrogen and Progesterone by Progesterone stimulant
  1.4.1 Japan Estrogen and Progesterone Sales () and Market Share by Progesterone stimulant (2012-2017)
  1.4.2 Global Estrogen and Progesterone Sales () and Market Share by Progesterone stimulant (2012-2017)
  1.4.3 Japan Estrogen and Progesterone Revenue (Million USD) and Market Share by Progesterone stimulant (2012-2017)
  1.4.4 Global Estrogen and Progesterone Revenue (Million USD) and Market Share by Progesterone stimulant (2012-2017)
  1.4.5 Japan Estrogen and Progesterone Price () by Progesterone stimulant (2012-2017)
  1.4.6 Global Estrogen and Progesterone Price () by Progesterone stimulant (2012-2017)
  1.4.7 Japan Estrogen and Progesterone Sales Growth Rate (%) by Progesterone stimulant (2012-2017)
  1.4.8 Global Estrogen and Progesterone Sales Growth Rate (%) by Progesterone stimulant (2012-2017)
  1.4.9 Norethisterone Acetate
  1.4.10 Ethynodiol diacetate
1.5 Global and Japan Classification of Estrogen and Progesterone by Antiprogestogen
  1.5.1 Japan Estrogen and Progesterone Sales () and Market Share by Antiprogestogen (2012-2017)
  1.5.2 Global Estrogen and Progesterone Sales () and Market Share by Antiprogestogen (2012-2017)
  1.5.3 Japan Estrogen and Progesterone Revenue (Million USD) and Market Share by Antiprogestogen (2012-2017)
  1.5.4 Global Estrogen and Progesterone Revenue (Million USD) and Market Share by Antiprogestogen (2012-2017)
  1.5.5 Japan Estrogen and Progesterone Price () by Antiprogestogen (2012-2017)
  1.5.6 Global Estrogen and Progesterone Price () by Antiprogestogen (2012-2017)
  1.5.7 Japan Estrogen and Progesterone Sales Growth Rate (%) by Antiprogestogen (2012-2017)
  1.5.8 Global Estrogen and Progesterone Sales Growth Rate (%) by Antiprogestogen (2012-2017)
  1.5.9 Aglepristone
  1.5.10 Mifepristone
1.6 Global and Japan Classification of Estrogen and Progesterone by Estrogenic stimulant
  1.6.1 Japan Estrogen and Progesterone Sales () and Market Share by Estrogenic stimulant (2012-2017)
  1.6.2 Global Estrogen and Progesterone Sales () and Market Share by Estrogenic stimulant (2012-2017)
  1.6.3 Japan Estrogen and Progesterone Revenue (Million USD) and Market Share by Estrogenic stimulant (2012-2017)
  1.6.4 Global Estrogen and Progesterone Revenue (Million USD) and Market Share by Estrogenic stimulant (2012-2017)
  1.6.5 Japan Estrogen and Progesterone Price () by Estrogenic stimulant (2012-2017)
  1.6.6 Global Estrogen and Progesterone Price () by Estrogenic stimulant (2012-2017)
  1.6.7 Japan Estrogen and Progesterone Sales Growth Rate (%) by Estrogenic stimulant (2012-2017)
  1.6.8 Global Estrogen and Progesterone Sales Growth Rate (%) by Estrogenic stimulant (2012-2017)
  1.6.9 Megestrol
  1.6.10 Estradiol
  1.6.11 Estradiol Acetate
1.7 Global and Japan Classification of Estrogen and Progesterone by Antiestrogen agent
  1.7.1 Japan Estrogen and Progesterone Sales () and Market Share by Antiestrogen agent (2012-2017)
  1.7.2 Global Estrogen and Progesterone Sales () and Market Share by Antiestrogen agent (2012-2017)
  1.7.3 Japan Estrogen and Progesterone Revenue (Million USD) and Market Share by Antiestrogen agent (2012-2017)
  1.7.4 Global Estrogen and Progesterone Revenue (Million USD) and Market Share by Antiestrogen agent (2012-2017)
  1.7.5 Japan Estrogen and Progesterone Price () by Antiestrogen agent (2012-2017)
  1.7.6 Global Estrogen and Progesterone Price () by Antiestrogen agent (2012-2017)
  1.7.7 Japan Estrogen and Progesterone Sales Growth Rate (%) by Antiestrogen agent (2012-2017)
  1.7.8 Global Estrogen and Progesterone Sales Growth Rate (%) by Antiestrogen agent (2012-2017)
  1.7.9 Afimoxifene
  1.7.10 Arzoxifene
1.8 Global and Japan Classification of Estrogen and Progesterone by Aromatase Inhibitor
  1.8.1 Japan Estrogen and Progesterone Sales () and Market Share by Aromatase Inhibitor (2012-2017)
  1.8.2 Global Estrogen and Progesterone Sales () and Market Share by Aromatase Inhibitor (2012-2017)
  1.8.3 Japan Estrogen and Progesterone Revenue (Million USD) and Market Share by Aromatase Inhibitor (2012-2017)
  1.8.4 Global Estrogen and Progesterone Revenue (Million USD) and Market Share by Aromatase Inhibitor (2012-2017)
  1.8.5 Japan Estrogen and Progesterone Price () by Aromatase Inhibitor (2012-2017)
  1.8.6 Global Estrogen and Progesterone Price () by Aromatase Inhibitor (2012-2017)
  1.8.7 Japan Estrogen and Progesterone Sales Growth Rate (%) by Aromatase Inhibitor (2012-2017)
  1.8.8 Global Estrogen and Progesterone Sales Growth Rate (%) by Aromatase Inhibitor (2012-2017)
  1.8.9 Aminoglutethimide
  1.8.10 Testolactone

2 GLOBAL AND JAPAN ESTROGEN AND PROGESTERONE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Estrogen and Progesterone Market Competition by Players/Manufacturers
  2.1.1 Japan Estrogen and Progesterone Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan Estrogen and Progesterone Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan Estrogen and Progesterone Average Price () by Players/Manufacturers (2012-2017)
  2.1.4 Japan Estrogen and Progesterone Market Competitive Situation and Trends
    2.1.4.1 Japan Estrogen and Progesterone Market Concentration Rate
    2.1.4.2 Japan Estrogen and Progesterone Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers Estrogen and Progesterone Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Estrogen and Progesterone Market Competition by Players/Manufacturers
  2.2.1 Global Estrogen and Progesterone Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global Estrogen and Progesterone Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global Estrogen and Progesterone Average Price () by Players/Manufacturers (2012-2017)
  2.2.4 Global Estrogen and Progesterone Market Competitive Situation and Trends
    2.2.4.1 Global Estrogen and Progesterone Market Concentration Rate
    2.2.4.2 Global Estrogen and Progesterone Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers Estrogen and Progesterone Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN ESTROGEN AND PROGESTERONE SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific Estrogen and Progesterone Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.1.1.1 Japan Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.1.1.2 Japan Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan Estrogen and Progesterone Price ()(2012-2017)
  3.1.2 China Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.1.2.1 China Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.1.2.2 China Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China Estrogen and Progesterone Price ()(2012-2017)
  3.1.3 Korea Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.1.3.1 Korea Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.1.3.2 Korea Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea Estrogen and Progesterone Price ()(2012-2017)
  3.1.4 India Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.1.4.1 India Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.1.4.2 India Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India Estrogen and Progesterone Price ()(2012-2017)
  3.1.5 Others Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.1.5.1 Others Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.1.5.2 Others Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others Estrogen and Progesterone Price ()(2012-2017)
3.2 Europe Estrogen and Progesterone Sales and Revenue by Regions (2012-2017)
  3.2.1 France Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.2.1.1 France Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.2.1.2 France Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France Estrogen and Progesterone Price ()(2012-2017)
  3.2.2 Germany Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.2.2.1 Germany Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.2.2.2 Germany Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany Estrogen and Progesterone Price ()(2012-2017)
  3.2.3 United Kingdom Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.2.3.2 United Kingdom Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom Estrogen and Progesterone Price ()(2012-2017)
  3.2.4 Italy Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.2.4.1 Italy Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.2.4.2 Italy Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy Estrogen and Progesterone Price ()(2012-2017)
  3.2.5 Russia Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.2.5.1 Russia Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.2.5.2 Russia Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia Estrogen and Progesterone Price ()(2012-2017)
  3.2.6 Others Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.2.6.1 Others Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.2.6.2 Others Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others Estrogen and Progesterone Price ()(2012-2017)
3.3 North America Estrogen and Progesterone Sales and Revenue by Regions (2012-2017)
  3.3.1 United States Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.3.1.1 United States Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.3.1.2 United States Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States Estrogen and Progesterone Price ()(2012-2017)
  3.3.2 Canada Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.3.2.1 Canada Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.3.2.2 Canada Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada Estrogen and Progesterone Price ()(2012-2017)
3.4 Latin America Estrogen and Progesterone Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.4.1.1 Brazil Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.4.1.2 Brazil Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil Estrogen and Progesterone Price ()(2012-2017)
  3.4.2 Mexico Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.4.2.1 Mexico Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.4.2.2 Mexico Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico Estrogen and Progesterone Price ()(2012-2017)
  3.4.3 Others Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.4.3.1 Others Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.4.3.2 Others Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others Estrogen and Progesterone Price ()(2012-2017)
3.5 Southeast Asia Estrogen and Progesterone Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.1.1 Singapore Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.1.2 Singapore Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore Estrogen and Progesterone Price ()(2012-2017)
  3.5.2 Malaysia Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.2.2 Malaysia Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia Estrogen and Progesterone Price ()(2012-2017)
  3.5.3 Vietnam Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.3.2 Vietnam Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam Estrogen and Progesterone Price ()(2012-2017)
  3.5.4 Myanmar Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.4.2 Myanmar Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar Estrogen and Progesterone Price ()(2012-2017)
  3.5.5 Thailand Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.5.1 Thailand Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.5.2 Thailand Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand Estrogen and Progesterone Price ()(2012-2017)
  3.5.6 Indonesia Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.6.2 Indonesia Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia Estrogen and Progesterone Price ()(2012-2017)
  3.5.7 Philippines Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.7.1 Philippines Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.7.2 Philippines Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines Estrogen and Progesterone Price ()(2012-2017)
  3.5.8 Others Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.5.8.1 Others Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.5.8.2 Others Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others Estrogen and Progesterone Price ()(2012-2017)
3.6 Middle East & Africa Estrogen and Progesterone Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia Estrogen and Progesterone Price ()(2012-2017)
  3.6.2 Iran Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.2.1 Iran Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.2.2 Iran Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran Estrogen and Progesterone Price ()(2012-2017)
  3.6.3 UAE Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.3.1 UAE Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.3.2 UAE Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE Estrogen and Progesterone Price ()(2012-2017)
  3.6.4 Turkey Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.4.1 Turkey Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.4.2 Turkey Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey Estrogen and Progesterone Price ()(2012-2017)
  3.6.5 Israel Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.5.1 Israel Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.5.2 Israel Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel Estrogen and Progesterone Price ()(2012-2017)
  3.6.6 Egypt Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.6.1 Egypt Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.6.2 Egypt Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt Estrogen and Progesterone Price ()(2012-2017)
  3.6.7 South Africa Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.7.1 South Africa Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.7.2 South Africa Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa Estrogen and Progesterone Price ()(2012-2017)
  3.6.8 Others Estrogen and Progesterone Sales and Revenue (2012-2017)
    3.6.8.1 Others Estrogen and Progesterone Sales () and Market Share (2012-2017)
    3.6.8.2 Others Estrogen and Progesterone Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others Estrogen and Progesterone Price ()(2012-2017)

4 GLOBAL AND JAPAN ESTROGEN AND PROGESTERONE PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Gedeon Richter Plc.
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Estrogen and Progesterone Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 Gedeon Richter Plc. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 Bayer Oy
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Estrogen and Progesterone Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 Bayer Oy Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 N.V.Organon
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Estrogen and Progesterone Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 N.V.Organon Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 Pfizer Healthcare Ireland
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Estrogen and Progesterone Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 Pfizer Healthcare Ireland Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 Jenapharm GmbH & Co. KG
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Estrogen and Progesterone Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 Besins Healthcare Benelux
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Estrogen and Progesterone Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 Besins Healthcare Benelux Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 MERCK SERONO LIMITED
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Estrogen and Progesterone Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 MERCK SERONO LIMITED Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview
4.8 Abbott Healthcare Products B.V.
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Estrogen and Progesterone Product Category, Application and Specification
    4.8.2.1 Product A
    4.8.2.2 Product B
  4.8.3 Abbott Healthcare Products B.V. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.8.4 Main Business/Business Overview
4.9 Teva Pharma - Produtos Farmaceuticos,Lda.
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Estrogen and Progesterone Product Category, Application and Specification
    4.9.2.1 Product A
    4.9.2.2 Product B
  4.9.3 Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.9.4 Main Business/Business Overview
4.10 Aspen Pharmacare Australia Pty Ltd.
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Estrogen and Progesterone Product Category, Application and Specification
    4.10.2.1 Product A
    4.10.2.2 Product B
  4.10.3 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.10.4 Main Business/Business Overview
4.11 Dr.Kade Pharmazeutische Fabrik GmbH
4.12 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
4.13 Eli Lilly Nederland B.V
4.14 Orion Corporation
4.15 AstraZeneca UK Limited
4.16 Novartis Pharma Schweiz AG

5 ESTROGEN AND PROGESTERONE MANUFACTURING COST ANALYSIS

5.1 Estrogen and Progesterone Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Estrogen and Progesterone

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 Estrogen and Progesterone Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Estrogen and Progesterone Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN ESTROGEN AND PROGESTERONE MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan Estrogen and Progesterone Sales (), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Estrogen and Progesterone Sales () Forecast by Type (2017-2022)
  9.2.1 by Progesterone stimulant
  9.2.2 by Antiprogestogen
  9.2.3 by Estrogenic stimulant
  9.2.4 by Antiestrogen agent
  9.2.5 by Aromatase Inhibitor
9.3 Global and Japan Estrogen and Progesterone Sales () Forecast by Application (2017-2022)
9.4 Global and Japan Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List
LIST OF TABLES AND FIGURES

Figure Product Picture of Estrogen and Progesterone
Table Japan Estrogen and Progesterone Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Estrogen and Progesterone by Applications in 2016
Table Global Estrogen and Progesterone Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Estrogen and Progesterone by Applications in 2016
Figure Examples
Table Key Downstream Customer in
Figure Examples
Table Key Downstream Customer in
Figure Norethisterone Acetate Product Picture
Figure Ethynodiol diacetate Product Picture
Figure Aglepristone Product Picture
Figure Mifepristone Product Picture
Figure Megestrol Product Picture
Figure Estradiol Product Picture
Figure Estradiol Acetate Product Picture
Figure Afimoxifene Product Picture
Figure Arzoxifene Product Picture
Figure Testolactone Product Picture
Table Gedeon Richter Plc. Basic Information List
Table Gedeon Richter Plc. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Gedeon Richter Plc. Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Gedeon Richter Plc. Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Gedeon Richter Plc. Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Bayer Oy Basic Information List
Table Bayer Oy Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Bayer Oy Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Bayer Oy Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Bayer Oy Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table N.V.Organon Basic Information List
Table N.V.Organon Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table N.V.Organon Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table N.V.Organon Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure N.V.Organon Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Pfizer Healthcare Ireland Basic Information List
Table Pfizer Healthcare Ireland Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Pfizer Healthcare Ireland Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Pfizer Healthcare Ireland Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Pfizer Healthcare Ireland Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Jenapharm GmbH & Co. KG Basic Information List
Table Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Besins Healthcare Benelux Basic Information List
Table Besins Healthcare Benelux Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Besins Healthcare Benelux Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Besins Healthcare Benelux Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Besins Healthcare Benelux Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table MERCK SERONO LIMITED Basic Information List
Table MERCK SERONO LIMITED Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table MERCK SERONO LIMITED Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table MERCK SERONO LIMITED Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure MERCK SERONO LIMITED Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Abbott Healthcare Products B.V. Basic Information List
Table Abbott Healthcare Products B.V. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Teva Pharma - Produtos Farmaceuticos,Lda. Basic Information List
Table Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Aspen Pharmacare Australia Pty Ltd. Basic Information List
Table Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Growth Rate (%)(2012-2017)
Table Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Market Share (%) in Japan (2012-2017)
Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Revenue Market Share (%) in Japan (2012-2017)
Table Dr.Kade Pharmazeutische Fabrik GmbH Basic Information List
Table F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Basic Information List
Table Eli Lilly Nederland B.V Basic Information List
Table Orion Corporation Basic Information List
Table AstraZeneca UK Limited Basic Information List
Table Novartis Pharma Schweiz AG Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Estrogen and Progesterone
Figure Manufacturing Process Analysis of Estrogen and Progesterone
Figure Estrogen and Progesterone Industrial Chain Analysis
Table Raw Materials Sources of Estrogen and Progesterone Major Players/Manufacturers in 2016
Table Major Buyers of Estrogen and Progesterone
Table Distributors/Traders List
Figure Japan Estrogen and Progesterone Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Japan Estrogen and Progesterone Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Estrogen and Progesterone Price () Trend Forecast (2017-2022)
Figure Global Estrogen and Progesterone Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Estrogen and Progesterone Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Estrogen and Progesterone Price () Trend Forecast (2017-2022)
Table Japan Estrogen and Progesterone Sales () Forecast by Type (2017-2022)
Table Global Estrogen and Progesterone Sales () Forecast by Type (2017-2022)
Figure Japan Estrogen and Progesterone Sales () Forecast by Type (2017-2022)
Figure Global Estrogen and Progesterone Sales () Forecast by Type (2017-2022)
Figure Japan Estrogen and Progesterone Sales Volume Market Share Forecast by Type in 2017
Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Type in 2017
Table Japan Estrogen and Progesterone Sales () Forecast by Application (2017-2022)
Figure Japan Estrogen and Progesterone Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Estrogen and Progesterone Sales Volume Market Share Forecast by Application in 2017
Table Global Estrogen and Progesterone Sales () Forecast by Application (2017-2022)
Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Application in 2017
Table Japan Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)
Table Japan Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
Table Global Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)
Table Global Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories